Kunming Qi

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng et al. · American Journal of Hematology · 2018 · 174 citations · Full text

Life Sciences, Immunology, Oncology +17

NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis

Jianlin Qiao, Xiaoqing Wu, Qi Luo et al. · Haematologica · 2018 · 123 citations · Full text

Medicine, Cell Biology, Molecular Biology +17

Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial

Ming Shi, Jiaojiao Wang, Hongming Huang et al. · Nature Communications · 2024 · 104 citations · Full text

Medicine, Immunology, Oncology +16

A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity

Huihui Zhang, Fanlin Li, Jiang Cao et al. · Science Translational Medicine · 2021 · 102 citations

Life Sciences, Immunology, Oncology +17

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Ying Wang, Chunrui Li, Jieyun Xia et al. · Blood Advances · 2021 · 102 citations · Full text

Life Sciences, Hematology, Immunology +17